Application of intranasal administration in the delivery of antidepressant active ingredients
Z Jin, Y Han, D Zhang, Z Li, Y Jing, B Hu, S Sun - Pharmaceutics, 2022 - mdpi.com
As a mental disease in modern society, depression shows an increasing occurrence, with
low cure rate and high recurrence rate. It has become the most disabling disease in the …
low cure rate and high recurrence rate. It has become the most disabling disease in the …
[HTML][HTML] Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: a randomized …
Background The high prevalence of depression is partly attributable to the poor response of
patients to first-line antidepressants. Multimodal programs that promote a healthy lifestyle …
patients to first-line antidepressants. Multimodal programs that promote a healthy lifestyle …
First experiences with esketamine nasal spray in patients with moderate and severe treatment-resistant depression
JMM García, MTP Lasala, MB Trancón, RJL Mellado… - Psiquiatría …, 2025 - Elsevier
We report 4 cases of female patients with treatment-resistant depression treated with
intranasal esketamine. The age of 2 patients were over 50, with only 1 patient in their 20s …
intranasal esketamine. The age of 2 patients were over 50, with only 1 patient in their 20s …
[PDF][PDF] Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 2022, 14, 2070
Z Jin, Y Han, D Zhang, Z Li, Y Jing, B Hu, S Sun - 2022 - pdfs.semanticscholar.org
As a mental disease in modern society, depression shows an increasing occurrence, with
low cure rate and high recurrence rate. It has become the most disabling disease in the …
low cure rate and high recurrence rate. It has become the most disabling disease in the …